As myogenic dysfunction has been linked to not only hypertension but also stroke, diabetes, and Alzheimer’s disease [50], it would be of future interest to explore the function of GRAF3 as a modifier of the pathological progression of such diseases. The gene discussed is ARHGAP42; the disease is early-onset autosomal dominant Alzheimer disease.